Brainomix Company
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Investors
%20.jpg)
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2010-01-01
Last Funding Date:
2021-12-16
Total Funding:
35017490
Employee Number:
9
Number Of Exists:
11-50
Estimated Revenue:
$33.16M
Investors Number:
6
Industry:
Aging Biomarkers